Skip to content
10-Q

Quarterly Report

Apollo Endosurgery, Inc.

0001251769-22-000081

← back to feed
Filed
Nov 1, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 28, 2022 41.63M sh
Shares Diluted Q3 2022 · Sep 30, 2022 40.85M sh
Shares Diluted Q3 2022 · Sep 30, 2022 40.29M sh
Shares Diluted Q3 2022 · Sep 30, 2021 29.02M sh
Shares Diluted Q3 2022 · Sep 30, 2021 27.54M sh
Capex Q3 2022 · Sep 30, 2022 $1.91M
Capex Q3 2022 · Sep 30, 2021 $743K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$20.96M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$10.12M
Long Term Debt Q3 2022 · Sep 30, 2022 $33.84M
Long Term Debt Q3 2022 · Dec 31, 2021 $33.47M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $66.91M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $90.69M
Stockholders Equity Q3 2022 · Sep 30, 2022 $42.31M
Stockholders Equity Q3 2022 · Jun 30, 2022 $48.16M
Stockholders Equity Q3 2022 · Dec 31, 2021 $61.24M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$92K
Stockholders Equity Q3 2022 · Jun 30, 2021 $2.71M
Stockholders Equity Q3 2022 · Dec 31, 2020 $6.75M
Current Liabilities Q3 2022 · Sep 30, 2022 $16.47M
Current Liabilities Q3 2022 · Dec 31, 2021 $14.49M
Total Liabilities Q3 2022 · Sep 30, 2022 $73.72M
Total Liabilities Q3 2022 · Dec 31, 2021 $70.29M
Current Assets Q3 2022 · Sep 30, 2022 $98.77M
Current Assets Q3 2022 · Dec 31, 2021 $114.7M
Total Assets Q3 2022 · Sep 30, 2022 $116.03M
Total Assets Q3 2022 · Dec 31, 2021 $131.53M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.28
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.75
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.23
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.52
Eps Basic Q3 2022 · Sep 30, 2022 −$0.28
Eps Basic Q3 2022 · Sep 30, 2022 −$0.75
Eps Basic Q3 2022 · Sep 30, 2021 −$0.23
Eps Basic Q3 2022 · Sep 30, 2021 −$0.52
Sga Expense Q3 2022 · Sep 30, 2022 $5.19M
Sga Expense Q3 2022 · Sep 30, 2022 $15.46M
Sga Expense Q3 2022 · Sep 30, 2021 $4.57M
Sga Expense Q3 2022 · Sep 30, 2021 $13.98M
Rd Expense Q3 2022 · Sep 30, 2022 $2.8M
Rd Expense Q3 2022 · Sep 30, 2022 $8.43M
Rd Expense Q3 2022 · Sep 30, 2021 $2.57M
Rd Expense Q3 2022 · Sep 30, 2021 $7.05M
Net Income Q3 2022 · Sep 30, 2022 −$11.45M
Net Income Q3 2022 · Sep 30, 2022 −$30.29M
Net Income Q3 2022 · Sep 30, 2021 −$6.66M
Net Income Q3 2022 · Sep 30, 2021 −$14.28M
Operating Income Q3 2022 · Sep 30, 2022 −$6.29M
Operating Income Q3 2022 · Sep 30, 2022 −$20.12M
Operating Income Q3 2022 · Sep 30, 2021 −$4.5M
Operating Income Q3 2022 · Sep 30, 2021 −$13.5M
Gross Profit Q3 2022 · Sep 30, 2022 $10.74M
Gross Profit Q3 2022 · Sep 30, 2022 $31.07M
Gross Profit Q3 2022 · Sep 30, 2021 $9.23M
Gross Profit Q3 2022 · Sep 30, 2021 $25.86M
Revenue Q3 2022 · Sep 30, 2022 $19.57M
Revenue Q3 2022 · Sep 30, 2022 $55.54M
Revenue Q3 2022 · Sep 30, 2021 $16.35M
Revenue Q3 2022 · Sep 30, 2021 $46.82M